REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

IM Pharma, Spol. S R.O. V Likvidacii (Slovakia)

Main Activities: Department Stores
Full name: IM Pharma, Spol. S R.O. V Likvidacii Profile Updated: October 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

IM Pharma, Spol. S R.O. V Likvidacii is based in Slovakia, with the head office in Presov. It operates in the Department Stores industry. It was first established on April 05, 2007. It currently has a total number of 3 - 4 (2025) employees. In 2025, the company reported a net sales revenue drop of 76.74%. There was a total growth of 89.32% in IM Pharma, Spol. S R.O. V Likvidacii’s total assets over the same period.

Headquarters
Capajevova, 23
Presov; Presovsky; Postal Code: 08001

Contact Details: Purchase the IM Pharma, Spol. S R.O. V Likvidacii report to view the information.

Basic Information
Total Employees:
Purchase the IM Pharma, Spol. S R.O. V Likvidacii report to view the information.
Registered Capital:
Purchase the IM Pharma, Spol. S R.O. V Likvidacii report to view the information.
Financial Auditors:
Purchase the IM Pharma, Spol. S R.O. V Likvidacii report to view the information.
Incorporation Date:
April 05, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
85%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after IM Pharma, Spol. S R.O. V Likvidacii report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-76.74%▼
Total Operating Revenue
23%▲
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
89.32%▲
Total Equity
596.07%▲
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.45%▲
Cash Ratio
1.1%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo